Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Coventry University Constructs Science and Health Building
Coventry University is constructing the $52 million Science and Health Building in the United Kingdom. The five-story multidisciplinary facility will provide classrooms, simulation training suites, science labs, and core research space for the Faculty of Health and Life Sciences. The 121,200-gsf (75,500-nsf) project is being built by BAM Construction. Completion is expected by fall of 2017.
Carolinas HealthCare Plans Levine Cancer Institute Expansion
Carolinas HealthCare System will begin construction in early 2017 on a $125 million expansion of the Levine Cancer Institute in Charlotte, N.C. A seven-story, 260,000-sf outpatient center will be built adjacent to the Institute's existing headquarters to provide additional space for oncology clinics, infusion therapy suites, and specialty pharmacy services.
University of Texas Rio Grande Valley Breaks Ground on Academic Building
The University of Texas Rio Grande Valley broke ground in March of 2016 on the $54 million Academic Building in Brownsville. Comprised of two three-story structures, the 102,551-sf complex will provide four chemistry labs, two environmental science labs, faculty offices, classrooms, and space for the School of Music. The project team includes Bartlett Cocke General Contractors and Garrett Mechanical.
Francis Marion University's Health Sciences Complex Nears Completion
Francis Marion University is building the Luther F. Carter Center for Health Sciences in Florence, S.C. The three-story, 51,000-sf complex will provide classrooms, faculty offices, laboratories, and simulation suites. The center will also house an auditorium, study areas, and space for clinical trials. The construction cost of the facility is $15.5 million. Completion is expected by July of 2016.
Novo Nordisk Breaks Ground on Clayton Pharmaceutical Manufacturing Plant
Novo Nordisk broke ground in March of 2016 on a $1.8 billion pharmaceutical manufacturing plant in Clayton, N.C. Built by Fluor Corporation, the 833,000-sf facility will produce active pharmaceutical ingredients for diabetes treatments and will accommodate 700 employees. Construction is slated for completion in 2019 with full operations commencing in 2021. Novo Nordisk is based in Bagsvaerd, Denmark.